With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
BD and Waters set Feb. 9 completion date for $17.5B biosciences and diagnostics merger
BD and Waters announced a plan to spin off BD’s biosciences and diagnostics business and merge it with a Waters subsidiary, targeting a Feb. 9 close after Waters stockholders approved issuing stock. The deal would give BD shareholders about 39.2% of the combined company and would double Waters’ total addressable market. BD set Feb. 5…